Nantes University Hospital
Nantes, France
NCT Number: NCT07830680
The goal of this observational study is to evaluate the expression of miR-10a-5p in the blood in patients with sexual addiction or food addiction. The main question it aims to answer is : To determine whether adults patients with SA or FA exhibit a distinct blood miR-10a-5p expression profile compared with matched healthy controls.
For all participants, one blood sample will be collected.
Trial opening soon.
Get Notified18 year and older
All sexes
Observational
Nantes, France
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
For patients with FA:
For healthy controls matched to patients with FA:
For patients with SA:
For healthy controls matched to patients with SA:
Exclusion criteria
For patients with FA:
For patients with SA:
For healthy controls:
One blood sample wiil be collected into a 10mL K2EDTA BD Vacutainer® tube
Time frame: 3 months
Quantitative comparison of blood miR-10a-5p expression levels between patients with SA or FA and matched healthy controls.
Time frame: 3 months
Quantitative comparison of blood expression levels of preselected candidate miRs between patients with SA or FA and matched healthy controls.
Time frame: 3 months
Association between blood expression levels of circulating miRs and clinical characteristics
Contact information is provided by the study sponsor or research team.
Nantes University Hospital
Other
Physiopathology of Behavioral Addictions and Biomarkers: microRNAs Implication - MiRACle : a Pilot Study.
Acronym: MiRACle
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05437809
Behavior, Behavior, Addictive
Philadelphia, Pennsylvania, United States
View Trial DetailsNCT06044285
Behavior, Behavior, Addictive
Ann Arbor, Michigan, United States
View Trial DetailsNCT07518056
Behavior, Behavior, Addictive
Istanbul, beşiktaş, Turkey (Türkiye)
View Trial DetailsNCT06030362
Behavior, Behavior, Addictive
Los Angeles, California, United States
View Trial Details